Literature DB >> 23756116

[Cognitive complaints in people with human immunodeficiency virus in Spain: prevalence and related variables].

José A Muñoz-Moreno1, Maria J Fuster-Ruiz de Apodaca2, Carmina R Fumaz3, Maria J Ferrer3, Fernando Molero4, Àngels Jaen5, Bonaventura Clotet6, David Dalmau5.   

Abstract

BACKGROUND AND
OBJECTIVE: Cognitive complaints have been scarcely studied in people with HIV in Spain. The aim of this research was to know the prevalence of cognitive complaints in HIV-infected people, as well as its potential relationships with demographic, clinical and psychological variables, in the era of combination antiretroviral therapies. PATIENTS AND
METHOD: Observational multicenter study developed in 4 hospitals and 10 NGOs, in which 791 people with HIV in Spain participated. A self-reported questionnaire was used to evaluate demographic and clinical variables, and an assessment of cognitive complaints, emotional status and quality of life variables was also included. Descriptive and inferential tests were used for statistical analyses.
RESULTS: Almost half of the sample (49.8%) referred cognitive complaints, in 72.1% of them an association with interference on daily living activities was found. Memory and attention were the areas most prevalently perceived as affected. The existence of cognitive complaints correlated with a longer HIV infection, lower CD4+ cell count, undetectable viral load and worse quality of life. A discriminant analysis determined that depression, anxiety, older age, living with no partner and low education level allowed to classify optimally HIV-infected people with cognitive complaints.
CONCLUSIONS: Self-reported cognitive complaints are frequent in people infected with HIV in the current era of combination antiretroviral therapies. This fact is related to emotional disturbances and poor quality of life, but also to impaired immunological and virological status.
Copyright © 2012 Elsevier España, S.L. All rights reserved.

Entities:  

Keywords:  Ansiedad; Antiretroviral therapy; Anxiety; Cognitive complaints; Depresión; Depression; Human immunodeficiency virus-infection; Infección por el virus de la inmunodeficiencia humana; Quejas cognitivas; Tratamiento antirretroviral

Mesh:

Year:  2013        PMID: 23756116     DOI: 10.1016/j.medcli.2013.02.037

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  3 in total

Review 1.  HIV-associated neurocognitive disorders.

Authors:  Montserrat Sanmarti; Laura Ibáñez; Sonia Huertas; Dolors Badenes; David Dalmau; Mark Slevin; Jerzy Krupinski; Aurel Popa-Wagner; Angeles Jaen
Journal:  J Mol Psychiatry       Date:  2014-03-04

2.  Development of a Clinic Screening Tool to Identify Burdensome Health-Related Issues Affecting People Living With HIV in Spain.

Authors:  Maria José Fuster-RuizdeApodaca; Kelly Safreed-Harmon; Marta Pastor de la Cal; Ana Laguia; Denise Naniche; Jeffrey V Lazarus
Journal:  Front Psychol       Date:  2021-06-09

3.  Recreational Drug Use in People Living with HIV in Spain: Factors Associated with Drug Use and the Impact on Clinical Outcomes.

Authors:  Vanessa Castro-Granell; María José Fuster-RuizdeApodaca; Noé Garin; Ángeles Jaén; José Luis Casado; Lorna Leal; Santiago Cenoz
Journal:  AIDS Behav       Date:  2021-05-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.